These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21394007)

  • 1. Clinical implications of stem cell gene Oct-4 expression in breast cancer.
    Liu CG; Lu Y; Wang BB; Zhang YJ; Zhang RS; Lu Y; Chen B; Xu H; Jin F; Lu P
    Ann Surg; 2011 Jun; 253(6):1165-71. PubMed ID: 21394007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
    Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
    Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
    Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
    Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
    Pandit TS; Kennette W; Mackenzie L; Zhang G; Al-Katib W; Andrews J; Vantyghem SA; Ormond DG; Allan AL; Rodenhiser DI; Chambers AF; Tuck AB
    Int J Oncol; 2009 Aug; 35(2):297-308. PubMed ID: 19578743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells: an overview.
    Ponti D; Zaffaroni N; Capelli C; Daidone MG
    Eur J Cancer; 2006 Jun; 42(9):1219-24. PubMed ID: 16624548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
    Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
    Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
    Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
    Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.
    Kim HJ; Kim MJ; Ahn SH; Son BH; Kim SB; Ahn JH; Noh WC; Gong G
    Breast; 2011 Feb; 20(1):78-85. PubMed ID: 20810282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer.
    Watanabe O; Kinoshita J; Shimizu T; Imamura H; Hirano A; Okabe T; Aiba M; Ogawa K
    J Exp Clin Cancer Res; 2005 Mar; 24(1):75-82. PubMed ID: 15943035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion.
    Trosko JE
    Ann N Y Acad Sci; 2006 Nov; 1089():36-58. PubMed ID: 17261754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
    Theodoropoulos PA; Polioudaki H; Agelaki S; Kallergi G; Saridaki Z; Mavroudis D; Georgoulias V
    Cancer Lett; 2010 Feb; 288(1):99-106. PubMed ID: 19619935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent translational research: stem cells as the roots of breast cancer.
    Chang CC
    Breast Cancer Res; 2006; 8(1):103. PubMed ID: 16524453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lapatinib study supports cancer stem cell hypothesis, encourages industry research.
    Schmidt C
    J Natl Cancer Inst; 2008 May; 100(10):694-5. PubMed ID: 18477795
    [No Abstract]   [Full Text] [Related]  

  • 19. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
    Fillmore C; Kuperwasser C
    Breast Cancer Res; 2007; 9(3):303. PubMed ID: 17540049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
    Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
    Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.